We use first- and third-party cookies to provide our services and collect statistical data. By continuing to browse you accept these cookies.
More information
Accept
Home
About us
NEURAXPHARM
HISTORY HIGHLIGHTS
EXECUTIVE COMMITTEE
COMMITED TO SOCIETY
CNS SPECIALIST
CNS FOCUS
THERAPEUTIC AREAS
CNS R&D STRATEGY
Products
OUR PORTFOLIO
CNS VALUE ADDED MEDICINES
CNS STANDARD GENERICS
CNS CONSUMER HEALTHCARE
Other Services
FDFs – LESVI
CMO / BFS
GENERIC DOSSIERS
APIs – INKE
DEVELOPMENT & MANUFACTURING
REGULATORY SUPPORT
JOIN US
CONTACT US
NEWSROOM
LINKEDIN
Neuraxpharm group
See Neuraxpharm’s sites
Austria
Czechia
France
Germany
Hungary
Italy
Poland
Portugal
Slovakia
Spain
United Kingdom
Manufacturing plants
FDFs | LESVI
APIs | INKE
Newsroom
NuPharm Group announces the acquisition of Laboratoire Biodim in France
03 JULY
This strategic acquisition enables NuPharm to enter France and expand its European footprint
Read more
Invent Farma / neuraxpharm Group announces the acquisition of FB Health in Italy
21 JUNE
First acquisition made by Invent Farma / neuraxpharm following the creation of the Group by funds advised by Apax Partners in August 2016
Read more
The Invent Farma / neuraxpharm Group became NuPharm Group
10 OCT
Following to the acquisition of the operating subsidiaries of Invent Farma and neuraxpharm, the new group was created under the name NuPharm Group
Read more
Funds advised by Apax Partners to acquire the operating subsidiaries of Invent Farma and neuraxpharm
08 JULY
Funds advised by Apax Partners to acquire the operating subsidiaries of Invent Farma and neuraxpharm
Read more
1
2
3
4
5
